Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

Topics - Drug Development


Refine by Date:
From: To:
Published April 24, 2014
Phase I trial to employ prediction marker using Evotec's Proteome platform Read More »
Published April 24, 2014
Will promote Crown’s translational services to clients in Japan Read More »
Published April 22, 2014
To develop and commercialize Chk1 program Read More »
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published April 15, 2014
New approaches aim to predict clinical success Read More »
Published April 10, 2014
Phase I trial of biologic candidate employs XmAb antibody platform Read More »
Published April 9, 2014
Aims to jump-start syringe development process Read More »
Published April 9, 2014
Shows partnership activity up 34% in 2013 Read More »
Published April 9, 2014
Aims to support long-term growth efforts Read More »
Published April 7, 2014
To employ Fleximer technology in ADC product development Read More »
Published April 4, 2014
Will be used to enhance infectious disease development program Read More »
Published April 2, 2014
Particle to provide design, formulation and cGMP supplies Read More »
Published April 2, 2014
To develop compounds for the potential treatment of cancer Read More »
Published April 1, 2014
Offers R&D incentive for French companies Read More »
Published April 1, 2014
To evaluate biomarkers for the discovery of novel therapies Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On